Holly Koblish

Director, Pharmacology

Incyte Research Institute

Holly Koblish

Holly received her Ph.D. in Molecular and Cell Biology from the University of Pennsylvania and completed her postdoctoral training at Princeton University. Prior to joining Incyte in 2006, Holly held scientific research positions with 3-Dimensional Pharmaceuticals and Johnson and Johnson. At Incyte, Holly has been involved in target validation and drug discovery efforts within oncology. She has been involved with a number of Incyte’s kinase programs, including PIM, FGFR and c-Met, and immuno-oncology programs including IDO1, arginase, GITR and OX40.

Follow Holly Koblish' at upcoming/ongoing conferences at gtcbio:

Immunotherapeutics & Immunomonitoring 2018